BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19246275)

  • 1. [Synthesis of Gal-BSA-SPIO and magnetic resonance imaging of ASG receptors in rabbits bearing liver VX2 tumor and human liver].
    Jia FG; Zhang XD; Xu YK; Meng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):191-4. PubMed ID: 19246275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of hepatomas in hyperplastic nodules induced in the rat liver: detection with superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Yamamoto H; Yamashita Y; Takahashi M
    Acad Radiol; 1996 Apr; 3(4):330-5. PubMed ID: 8796683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
    Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
    Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.
    Kim SH; Lee WJ; Lim HK; Park CK
    Korean J Radiol; 2009; 10(2):112-20. PubMed ID: 19270856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of dual contrast liver MRI at 3.0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: preliminary results of multivariate analysis.
    Yoon MA; Kim SH; Park HS; Lee DH; Lee JY; Han JK; Choi BI
    Invest Radiol; 2009 Oct; 44(10):641-9. PubMed ID: 19724237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
    Inoue T; Kudo M; Hatanaka K; Takahashi S; Kitai S; Ueda T; Ishikawa E; Hagiwara S; Minami Y; Chung H; Ueshima K; Maekawa K
    Oncology; 2008; 75 Suppl 1():48-54. PubMed ID: 19092272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
    Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
    Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
    Liu X; Xu YK; Huang QL; Wu YK
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between SPIO-enhanced magnetic resonance imaging (MRI) and histological grading in hepatocellular carcinoma].
    Zhang XH; Liang BL; Huang SQ
    Ai Zheng; 2003 Jul; 22(7):734-8. PubMed ID: 12866966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
    Ma HL; Xu YF; Qi XR; Maitani Y; Nagai T
    Int J Pharm; 2008 Apr; 354(1-2):217-26. PubMed ID: 18191350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor imaging: application to MR imaging of liver cancer.
    Reimer P; Weissleder R; Lee AS; Wittenberg J; Brady TJ
    Radiology; 1990 Dec; 177(3):729-34. PubMed ID: 2243978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: Comparison of nine pulse sequences.
    Kim SH; Choi D; Lim HK; Kim MJ; Jang KM; Kim SH; Lee WJ; Lee J; Jeon YH; Lim JH
    Eur J Radiol; 2006 Sep; 59(3):413-23. PubMed ID: 16678373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis.
    Macarini L; Marini S; Murrone M; Ettorre GC
    Radiol Med; 2004; 108(1-2):92-106. PubMed ID: 15269693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading.
    Imai Y; Murakami T; Yoshida S; Nishikawa M; Ohsawa M; Tokunaga K; Murata M; Shibata K; Zushi S; Kurokawa M; Yonezawa T; Kawata S; Takamura M; Nagano H; Sakon M; Monden M; Wakasa K; Nakamura H
    Hepatology; 2000 Aug; 32(2):205-12. PubMed ID: 10915725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma with marginal superparamagnetic iron oxide uptake on T2*-weighted magnetic resonance imaging: histopathologic correlation.
    Ishigami K; Tajima T; Fujita N; Nishie A; Asayama Y; Kakihara D; Nakayama T; Okamoto D; Taketomi A; Shirabe K; Honda H
    Eur J Radiol; 2011 Dec; 80(3):e293-8. PubMed ID: 21288675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems.
    Kim T; Murakami T; Hori M; Onishi H; Tomoda K; Nakamura H
    J Magn Reson Imaging; 2009 Mar; 29(3):595-600. PubMed ID: 19243054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.